1,020
Participants
Start Date
September 1, 2021
Primary Completion Date
June 18, 2025
Study Completion Date
June 18, 2025
semaglutide
Oral administration The doctor will give a prescription for the medicine and tell how to take it.
oral glucose-lowering medications (commercially available)
Oral administration The doctor will give a prescription for the medicine and tell how to take it.
Preferred Primary Care Physicians_Pittsburgh, Pittsburgh
Tristar Clin Investigations, PC, Philadelphia
Kernodle Clin Dpt-Pvt Diagnost, Burlington
WakeMed Garner Hlthplx, Garner
OnSite Clinical Solutions, LLC_Charlotte, Charlotte
AnMed Health IMA, Anderson
DC Research Works, Marietta
Urban Family Practice Assoc, Marietta
Reyes Clinical Research, Inc, Miami
Central Ohio Clinical Research LLC, Columbus
Diab & Endo Assoc of Stark Co, Canton
Valley Weight Loss Clinic, Fargo
Endeavor Health, Skokie
UnityPoint Health-Diabetes Care Center, Peoria
Macoupin Research Group, Gillespie
Baylor Scott & White Res Inst, Dallas
Hill Country Medical Associates, New Braunfels
DCT-Stone Oak, San Antonio
Chrysalis Clinical Research, St. George
Scripps Whittier Diabetes Inst, La Jolla
FDRC, Costa Mesa
Jefferson Endocrinology Assocs, Philadelphia
Lead Sponsor
Novo Nordisk A/S
INDUSTRY